Successful treatment of simultaneous malignant pleural mesothelioma and pulmonary adenocarcinoma: A case report
Oncol Lett. 2024 Feb 15;27(4):155. doi: 10.3892/ol.2024.14288. eCollection 2024 Apr.ABSTRACTThe present report described the case of a 74-year-old male patient with asbestos exposure whose chest computed tomography revealed a right lower lobe nodule and right pleural effusion. Pleural biopsy led to the diagnosis of epithelial malignant pleural mesothelioma (cT2N0M0, stage IB). Combination therapy with cisplatin + pemetrexed led to the complete remission of malignant pleural mesothelioma; however, the right lower lobe nodule grew in size over time. The patient was subsequently diagnosed with lung adenocarcinoma (cT1aN0M0, s...
Source: Oncology Letters - March 1, 2024 Category: Cancer & Oncology Authors: Yuki Amakusa Tatsuro Suzuki Yu Hikosaka Masaya Takemura Tetsuya Oguri Source Type: research
A radiotherapy community data-driven approach to determine which complexity metrics best predict the impact of atypical TPS beam modeling on clinical dose calculation accuracy
CONCLUSION: Extreme values for MLC offset and MLC transmission beam modeling parameters were found to most substantially impact the dose distribution of clinical plans and careful attention should be given to these beam modeling parameters. The mean MLC Gap and TGi complexity metrics were best suited to identifying clinical plans most sensitive to beam modeling errors; this could help provide focus for clinical QA in identifying unacceptable plans.PMID:38427776 | DOI:10.1002/acm2.14318 (Source: Journal of Applied Clinical Medical Physics)
Source: Journal of Applied Clinical Medical Physics - March 1, 2024 Category: Physics Authors: Fre'Etta Mae Dayo Brooks Mallory Carson Glenn Victor Hernandez Jordi Saez Hunter Mehrens Julianne Marie Pollard-Larkin Rebecca Maureen Howell Christine Burns Peterson Christopher Lee Nelson Catharine Helen Clark Stephen Frasier Kry Source Type: research
Successful treatment of simultaneous malignant pleural mesothelioma and pulmonary adenocarcinoma: A case report
Oncol Lett. 2024 Feb 15;27(4):155. doi: 10.3892/ol.2024.14288. eCollection 2024 Apr.ABSTRACTThe present report described the case of a 74-year-old male patient with asbestos exposure whose chest computed tomography revealed a right lower lobe nodule and right pleural effusion. Pleural biopsy led to the diagnosis of epithelial malignant pleural mesothelioma (cT2N0M0, stage IB). Combination therapy with cisplatin + pemetrexed led to the complete remission of malignant pleural mesothelioma; however, the right lower lobe nodule grew in size over time. The patient was subsequently diagnosed with lung adenocarcinoma (cT1aN0M0, s...
Source: Oncology Letters - March 1, 2024 Category: Cancer & Oncology Authors: Yuki Amakusa Tatsuro Suzuki Yu Hikosaka Masaya Takemura Tetsuya Oguri Source Type: research
UV1 telomerase vaccine with ipilimumab and nivolumab as second line treatment for pleural mesothelioma – a phase II randomised trial
The NIPU-trial investigates the effect of adding the telomerase vaccine UV1 to treatment with ipilimumab and nivolumab for patients with pleural mesothelioma (PM). (Source: European Journal of Cancer)
Source: European Journal of Cancer - March 1, 2024 Category: Cancer & Oncology Authors: Vilde Drageset Haakensen, Åsa Kristina Öjlert, Solfrid Thunold, Saima Farooqi, Anna K Nowak, Wee L Chin, Oscar Grundberg, Weronika Maria Szejniuk, Susana Cedres, Jens Benn Sørensen, Tonje Sofie Dalen, Marius Lund-Iversen, Maria Bjaanæs, Åslaug Hellan Tags: Clinical Trial Source Type: research
